Naslov
Consumption of polyvalent immunoglobulins according to indications

Autori
Lukic, Marija ; Raos, Mirela ; Golubic Cepulic, Branka

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstracts of the 35th international congress of the ISBT, Vox Sanguinis. 2018 ; 113(S1) / - , 2018, 325-325

Skup
35th International Congress of the ISBT

Mjesto i datum
Toronto, Kanada, 02.06.2018. - 06.06.2018

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Polyvalent immunoglobulins ; indication

Sažetak
Polyvalent immunoglobulins (IGs), both intravenous (IVIG) and subcutaneous (SCIG), are used in the replacement therapy for primary immunodeficiency and in immunomodulating treatment of autoimmune diseases and neuroimmunological disorders. In the last decades, indications have been extended to secondary immunodeficiency, especially to haematological diseases such, as lymphoproliferative diseases (LPDs) and multiple myeloma (MM). Furthermore, IG are used for iatrogenic hypogammaglobulinemia due to immunotherapy (e.g. Rituximab), in immunosuppressive therapies (steroids, sulfasalazine, mycophenolate mofetil) and bone marrow (BMT) or solid organ transplantation. In clinical usage, when there is a lack of scientifically proven benefit, IG therapy is applied off-label. Aims: The aim of this study is to retrospectively analyze the usage of IG according to the indications.

Izvorni jezik
Engleski

POVEZANOST RADA